From Information to Innovation
The member companies of the IGES Group contribute to designing infrastructures: for healthcare, transport, housing and education. For more than 40 years we have delivered research and consulting services – analyses, expert opinions, studies, concepts and strategies – in Europe.
6,000
Projects
200
Employees
14
Companies
6
Countries
Business division
Public Infrastructures in Germany
Business division
![BIO 2024 International Convention](/sites/igesgroup/iges.de/myzms/content/e2856/e14976/e70968/iStock-1090224400_GR_eng.jpg)
BIO 2024 International Convention
The panel “Europe's Policy Environment and the Impact on the Biotech Sector” analyzed the proposed revisions to the General Pharmaceutical Legislation (GPL) , including changes to regulatory data protection. » Details
![IGES Institut](/sites/igesgroup/iges.de/myzms/content/e9993/boxItem27308/iStock-485310095_Fin2_eng.jpg)
Expert opinion on the calculation of capital costs for railway infrastructure
Bundesnetzagentur sets capital costs lower than DB Netz AG. » Details
![Bio Europe 2023](/sites/igesgroup/iges.de/myzms/content/e2856/e14976/e30730/REI-PHARMAEurope_2023_560x380px_ger.jpg)
EU HTA harmonisation under time pressure: discussion at the biotech congress "BIO Europe 2023
The time pressure due to EU HTA harmonisation is growing. In less than 15 months, the first medicinal products will have to undergo a central clinical evaluation procedure. IGES looks ahead to the start at BIO Europe 2023. » Details
![IGES France Pharma Consulting](/sites/igesgroup/iges.de/myzms/content/e6666/e29693/e30712/iStock-154123488_GR_ger.jpg)
IGES sets up a new subsidiary in France – IGES France Pharma Consulting
The IGES Group continues to grow and has set up IGES France Pharma Consulting to proposes strategic and health economics consulting services for the developers and manufacturers of medicinal products seeking to place products on the French and European markets. » Details
![Synergus RWE](/sites/igesgroup/iges.de/myzms/content/e6666/e29693/e29195/iStock-1397803547_GR_eng.jpg)
IGES acquires majority stake in Synergus RWE – a European Medtech market access specialist
IGES Group continues to expand its consulting services for developers and manufacturers of medical devices. To this end, the IGES Institute has acquired a majority stake in Synergus RWE. » Details
![Evaluation of long-term care advice](/sites/igesgroup/iges.de/myzms/content/e6/e1621/e10211/e29580/e30331/30761035_GR_ger.jpg)
Evaluation of long-term care advice
The care counselling services provided by the long-term care insurance funds have been further expanded and the majority of people in need of care, including their relatives, are satisfied with them. However, there is still room for improvement. » Details
IGES
Companies of the IGES Group
Business Area
Public Infrastructures in Germany, Austria, Switzerland
- Health
- Transport
- Education
- Housing
Business Area
LifeScience - Access to Europe
- Medtech
- Pharmaceuticals
- Digital Health